Global Glomerulonephritis Treatment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Glomerulonephritis Treatment

• 1.1 Definition of Glomerulonephritis Treatment
• 1.2 Glomerulonephritis Treatment Segment by Type
  • 1.2.1 Global Glomerulonephritis Treatment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ACH-5228
  • 1.2.3 AMY-101
  • 1.2.4 Atacicept
  • 1.2.5 Avacopan
  • 1.2.6 AVX-002
• 1.3 Glomerulonephritis Treatment Segment by Applications
  • 1.3.1 Global Glomerulonephritis Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Home Care
  • 1.3.3 Clinic
  • 1.3.4 Hospital
• 1.4 Global Glomerulonephritis Treatment Overall Market
  • 1.4.1 Global Glomerulonephritis Treatment Revenue (2014-2025)
  • 1.4.2 Global Glomerulonephritis Treatment Production (2014-2025)
  • 1.4.3 North America Glomerulonephritis Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Glomerulonephritis Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Glomerulonephritis Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Glomerulonephritis Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Glomerulonephritis Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Glomerulonephritis Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Glomerulonephritis Treatment
• 2.3 Manufacturing Process Analysis of Glomerulonephritis Treatment
• 2.4 Industry Chain Structure of Glomerulonephritis Treatment

3 Development and Manufacturing Plants Analysis of Glomerulonephritis Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Glomerulonephritis Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Glomerulonephritis Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Glomerulonephritis Treatment Production and Capacity Analysis
• 4.2 Glomerulonephritis Treatment Revenue Analysis
• 4.3 Glomerulonephritis Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Glomerulonephritis Treatment Regional Market Analysis

• 5.1 Glomerulonephritis Treatment Production by Regions
  • 5.1.1 Global Glomerulonephritis Treatment Production by Regions
  • 5.1.2 Global Glomerulonephritis Treatment Revenue by Regions
• 5.2 Glomerulonephritis Treatment Consumption by Regions
• 5.3 North America Glomerulonephritis Treatment Market Analysis
  • 5.3.1 North America Glomerulonephritis Treatment Production
  • 5.3.2 North America Glomerulonephritis Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Glomerulonephritis Treatment Import and Export
• 5.4 Europe Glomerulonephritis Treatment Market Analysis
  • 5.4.1 Europe Glomerulonephritis Treatment Production
  • 5.4.2 Europe Glomerulonephritis Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Glomerulonephritis Treatment Import and Export
• 5.5 China Glomerulonephritis Treatment Market Analysis
  • 5.5.1 China Glomerulonephritis Treatment Production
  • 5.5.2 China Glomerulonephritis Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Glomerulonephritis Treatment Import and Export
• 5.6 Japan Glomerulonephritis Treatment Market Analysis
  • 5.6.1 Japan Glomerulonephritis Treatment Production
  • 5.6.2 Japan Glomerulonephritis Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Glomerulonephritis Treatment Import and Export
• 5.7 Southeast Asia Glomerulonephritis Treatment Market Analysis
  • 5.7.1 Southeast Asia Glomerulonephritis Treatment Production
  • 5.7.2 Southeast Asia Glomerulonephritis Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Glomerulonephritis Treatment Import and Export
• 5.8 India Glomerulonephritis Treatment Market Analysis
  • 5.8.1 India Glomerulonephritis Treatment Production
  • 5.8.2 India Glomerulonephritis Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Glomerulonephritis Treatment Import and Export

6 Glomerulonephritis Treatment Segment Market Analysis (by Type)

• 6.1 Global Glomerulonephritis Treatment Production by Type
• 6.2 Global Glomerulonephritis Treatment Revenue by Type
• 6.3 Glomerulonephritis Treatment Price by Type

7 Glomerulonephritis Treatment Segment Market Analysis (by Application)

• 7.1 Global Glomerulonephritis Treatment Consumption by Application
• 7.2 Global Glomerulonephritis Treatment Consumption Market Share by Application (2014-2019)

8 Glomerulonephritis Treatment Major Manufacturers Analysis

• 8.1 Achillion Pharmaceuticals Inc
  • 8.1.1 Achillion Pharmaceuticals Inc Glomerulonephritis Treatment Production Sites and Area Served
  • 8.1.2 Achillion Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.1.3 Achillion Pharmaceuticals Inc Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Anthera Pharmaceuticals Inc
  • 8.2.1 Anthera Pharmaceuticals Inc Glomerulonephritis Treatment Production Sites and Area Served
  • 8.2.2 Anthera Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.2.3 Anthera Pharmaceuticals Inc Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Biogen Inc
  • 8.3.1 Biogen Inc Glomerulonephritis Treatment Production Sites and Area Served
  • 8.3.2 Biogen Inc Product Introduction, Application and Specification
  • 8.3.3 Biogen Inc Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Bristol-Myers Squibb Company
  • 8.4.1 Bristol-Myers Squibb Company Glomerulonephritis Treatment Production Sites and Area Served
  • 8.4.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
  • 8.4.3 Bristol-Myers Squibb Company Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Cellmid Ltd
  • 8.5.1 Cellmid Ltd Glomerulonephritis Treatment Production Sites and Area Served
  • 8.5.2 Cellmid Ltd Product Introduction, Application and Specification
  • 8.5.3 Cellmid Ltd Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 ChemoCentryx Inc
  • 8.6.1 ChemoCentryx Inc Glomerulonephritis Treatment Production Sites and Area Served
  • 8.6.2 ChemoCentryx Inc Product Introduction, Application and Specification
  • 8.6.3 ChemoCentryx Inc Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Complexa Inc
  • 8.7.1 Complexa Inc Glomerulonephritis Treatment Production Sites and Area Served
  • 8.7.2 Complexa Inc Product Introduction, Application and Specification
  • 8.7.3 Complexa Inc Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Dimerix Bioscience Pty Ltd
  • 8.8.1 Dimerix Bioscience Pty Ltd Glomerulonephritis Treatment Production Sites and Area Served
  • 8.8.2 Dimerix Bioscience Pty Ltd Product Introduction, Application and Specification
  • 8.8.3 Dimerix Bioscience Pty Ltd Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 GlaxoSmithKline Plc
  • 8.9.1 GlaxoSmithKline Plc Glomerulonephritis Treatment Production Sites and Area Served
  • 8.9.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
  • 8.9.3 GlaxoSmithKline Plc Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Merck KGaA
  • 8.10.1 Merck KGaA Glomerulonephritis Treatment Production Sites and Area Served
  • 8.10.2 Merck KGaA Product Introduction, Application and Specification
  • 8.10.3 Merck KGaA Glomerulonephritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Omeros Corp
• 8.12 Pfizer Inc
• 8.13 Pharmalink AB
• 8.14 Ra Pharmaceuticals Inc
• 8.15 Retrophin Inc
• 8.16 Rigel Pharmaceuticals Inc
• 8.17 Shire Plc
• 8.18 Visterra Inc

9 Development Trend of Analysis of Glomerulonephritis Treatment Market

• 9.1 Global Glomerulonephritis Treatment Market Trend Analysis
  • 9.1.1 Global Glomerulonephritis Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Glomerulonephritis Treatment Regional Market Trend
  • 9.2.1 North America Glomerulonephritis Treatment Forecast 2019-2025
  • 9.2.2 Europe Glomerulonephritis Treatment Forecast 2019-2025
  • 9.2.3 China Glomerulonephritis Treatment Forecast 2019-2025
  • 9.2.4 Japan Glomerulonephritis Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Glomerulonephritis Treatment Forecast 2019-2025
  • 9.2.6 India Glomerulonephritis Treatment Forecast 2019-2025
• 9.3 Glomerulonephritis Treatment Market Trend (Product Type)
• 9.4 Glomerulonephritis Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Glomerulonephritis Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List